Global Portfolio Toxicologic Pathology Lead

U175 (FCRS = US175) Novartis Institutes for BioMedical Research, Inc.; Cambridge (MA); Hybrid; USD 186,000 - 345,000; Full time

Benefits offered by this job

Health benefits

Life benefits

Disability benefits

401(k) with company match

Generous time off

Job summary

Novartis Institutes for BioMedical Research, Inc. in Cambridge, MA seeks an Associate Director to lead toxicologic pathology within Global Portfolio Pathology.

You will drive strategies for pathology, nonclinical safety, and drug development, shaping narratives for complex datasets and enabling rapid, high-quality decisions in small molecules, biologics, and new modalities. You will oversee IHC/ISH/ RNAscope and emerging -omics approaches, guiding risk-based recommendations and regulatory

Qualifications

• DVM or BVSc plus graduate pathology training.
• Board certification in pathology (DACVP or equivalent).
• 5+ years in toxicologic pathology.
• PhD in a relevant field preferred.
• Strong leadership and communication skills.

Responsibilities

• Build and lead multidisciplinary teams across pathology and related fields.
• Set next-generation non-GLP/GLP standards for reporting and data integrity.
• Serve as site scientific authority for pathology and biodistribution.
• Architect the investigative pathology strategy (IHC, ISH/RNAscope, digital/spatial pathology).
• Guide portfolio decisions through governance and matrix leadership.
• Lead innovation and vision for how pathology enables modern drug development.

Skills

Toxicologic pathology

Team leadership

Scientific communication

Regulatory writing

Data storytelling

Education

DVM / BVSc

Graduate pathology training

DACVP or equivalent

PhD in relevant field

Tools

IHC

ISH/RNAscope

Digital pathology

Spatial pathology

Job description

Novartis Institutes for BioMedical Research, Inc. in Cambridge, MA seeks an Associate Director to lead toxicologic pathology within Global Portfolio Pathology.

You will drive strategies for pathology, nonclinical safety, and drug development, shaping narratives for complex datasets and enabling rapid, high-quality decisions in small molecules, biologics, and new modalities. You will oversee IHC/ISH/ RNAscope and emerging -omics approaches, guiding risk-based recommendations and regulatory